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Synopsis
Reactions of H[AuCl4] with pyridyl-2-
alkylsulfonamides 
C5H4N(CH2)nNHSO2R (n = 1,2; R = Me, 
Ph or p-C6H4Me) or 8-(p-
tosylamino)quinoline in water gives high 
yields of cycloaurated complexes 
coordinated through the pyridyl (or 
quinolyl) nitrogen atom and the 
deprotonated nitrogen of the 
sulfonamide group.  
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Abstract 
The pyridyl-2-alkylsulfonamides C5H4N(CH2)nNHSO2R (n = 1,2; R = Me, Ph or p-
C6H4Me) and 8-(p-tosylamino)quinoline undergo facile cycloauration reactions with 
H[AuCl4] in water, giving metallacyclic complexes coordinated through the pyridyl (or 
quinolyl) nitrogen atom and the deprotonated nitrogen of the sulfonamide group. The 
complexes have been fully characterised by NMR spectroscopy, ESI mass spectrometry 
and elemental analysis. The X-ray crystal structures of two derivatives reveal the 
presence of non-planar sulfonamide nitrogen atoms. The complexes show low activity 
against P388 murine leukaemia cells, possibly as a result of their ease of reduction with 
mild reducing agents. 
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Introduction 
 
 Compared with the extensive chemistry of cyclometallated gold(III) complexes 
containing C,N donor ligands,
1
 little research has been conducted on analogous 
cycloaurated complexes stabilised by N,N’ donor ligands. Complexes derived from the 
primary amide picolinamide
2,3 
1 and substituted analogues 2
4
 and 3
5
, the dinuclear 
complex 4
6
 and the substituted 2-(pyrrol-2-yl)pyridine ligand 5
7
 are examples of the 
systems prepared. In addition, the ionic species 6-8 formed by the tridentate coordination 
of quinoline-derived ligands have also been investigated
8
 and related gold(III) complexes 
containing anionic chelating N,N’ ligands such as tri- and tetrakis-pyrazolylborates are 
 4 
also known.
9
 A recent report has described the cycloauration of bis(2-
pyridylmethyl)amine, giving complex 9.
10
 
 Because C,N stabilised complexes exhibit interesting chemistry and biological 
activity,
1
 we wished to synthesise related N,N’-stabilised species and assess their 
chemical and biological properties. Pyridylsulfonamide compounds [of the type 
C5H4N(CH2)nNHSO2R (n = 1,2; R = Me, Ph or p-C6H4Me)] were attractive ligands for 
this study due to the ease of synthesis, the opportunity of introducing variable R groups 
and the possibility of variable ring sizes in the subsequent cyclometallated complexes. In 
addition, cyclometallated complexes of this type containing a variety of metals are also 
known in the literature and show interesting applications.
11
 In this paper we describe the 
synthesis of six new auracyclic compounds and investigations into the reactivity and 
biological activity of these complexes. 
 
 
Results and discussion 
 
Syntheses 
 
 When the ligands HL
1
 to HL
6
 (Scheme 1) are refluxed in aqueous H[AuCl4] in a 
1:1 mole ratio, the auracyclic compounds L
1
AuCl2 to L
6
AuCl2 (Scheme 2) are easily 
isolated in excellent yields by filtration of the yellow to brown solid that is present 
throughout the reaction, the exception being L
3
AuCl2 which required cooling to induce 
crystallisation. This synthetic procedure is analogous to the preparation of 1
2,3
 however, 
similar reactions of the secondary amines 10 and 11 only afforded the salts 12 and 13.
7
 
The difference in the reactivity can be attributed to the decreased acidity of the NH 
protons in the ligands 10 and 11 relative to the sulfonamide counterparts. NMR and IR 
 5 
spectroscopy, along with ESI mass spectrometry indicate the nitrogen donor ligands are 
coordinated to gold through the neutral pyridyl donor and the anionic amido group. The 
formulation was confirmed by X-ray crystal structures of the complexes L
3
AuCl2 and 
L
6
AuCl2. 
 Attempted preparation of the analogous four-membered auracyclic system 
L
7
AuCl2 from HL
7
 proved unsuccessful. When HL
7
 was refluxed with H[AuCl4] in either 
an aqueous or an acetonitrile/water (1:1) solution, or alternatively mixed with HL
7
 in an 
aqueous acetonitrile solution of H[AuCl4] at room temperature, the only product was the 
salt [H2L
7
][AuCl4]. This was identified by 
1
H and 
13
C NMR spectroscopy and the 
presence of both the [H2L
7
]
+
 and [AuCl4]
-
 ions in positive- and negative-ion ESI mass 
spectra respectively. 
 
X-ray crystal structures of L
3
AuCl2 and L
6
AuCl2 
 Single crystal X-ray structure analyses of L
3
AuCl2 and L
6
AuCl2 were carried out 
in order to confirm the bonding of the ligand to the gold. In both cases, the ligands are 
deprotonated at the sulfonamide nitrogen and bonded to the gold through the two 
nitrogen atoms, with the remaining sites on the metal occupied by two chloride ligands.  
L
3
AuCl2 crystallises with two independent molecules per unit cell. Diagrams of the 
molecular structures of L
3
AuCl2 and L
6
AuCl2, along with the atom numbering schemes, 
are shown in Figures 1 and 2 respectively. Important bond lengths and angles are 
presented in Tables 1 and 2. 
 For both L
3
AuCl2 and L
6
AuCl2, the geometry around the d
8
 gold centre is 
essentially square planar, with the bite angle of the sulfonamide ligand less than 90° in 
 6 
both cases (Table 2). In L
3
AuCl2, the atom with the greatest deviation from the metal 
coordination plane [defined by Au(1), N(1), N(2), Cl(1) and Cl(2)] is N(1) [0.0817(15) 
Å] and Au(1) [0.0280(10) Å] for molecules 1 and 2 respectively. For L
6
AuCl2, the gold 
atom shows the greatest deviation from the coordination plane [defined by Au(1), N(1), 
N(2), Cl(1) and Cl(2)], sitting 0.0514(8) Å above the plane.  
 In all cases, the coordination around the deprotonated sulfonamide nitrogen N(2) 
is not planar, and is slightly distorted towards tetrahedral geometry, with the angles 
around the nitrogen adding to 358.6° (molecule 1) and 344.2° (molecule 2) for L
3
AuCl2, 
and 353.7° for L
6
AuCl2. Such distortion has previously been observed and discussed by 
Otter et al for copper(II), cobalt(II) and palladium(II) compounds of the type ML2 (L = 
N-(2-pyridin-2-yl-phenyl)-p-toluenesulfonamide).
12
 In addition, similar cyclometallated 
gold(III)
13
 and platinum(II)
14
 compounds also show this type of behaviour. 
 In both molecules of L
3
AuCl2, the cycloaurated ring [defined by Au(1), C(1), 
C(5), N(1) and N(2)] is in a envelope conformation with N(2) sitting above the ring (by 
0.286(2) Å and 0.206(2) Å for molecules 1 and 2 respectively). Due to the increased 
rigidity imposed by the aromatic ring system, in L
6
AuCl2 it is Au(1) that shows the 
greatest deviation from the plane [defined by C(1)-C(9), N(1) and N(2)], sitting 0.339(3) 
Å above the plane of the quinoline ring system (Figure 3). 
 For L
3
AuCl2 the gold-sulfonamide nitrogen bond length is shorter than the gold-
pyridyl nitrogen bond length, but the opposite is observed in the structure of L
6
AuCl2. 
The rigidity imposed on the system by the quinoline moiety in L
6
AuCl2, in comparison to 
the flexibility of L
3
AuCl2 system, is the probable cause of this discrepancy.  
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NMR and IR spectroscopic characterisation 
 Compounds of the type LAuCl2 were most suited to analysis by NMR 
spectroscopy. The effect of coordination of the gold to the ligand through the 
deprotonated sulfonamide nitrogen and pyridyl nitrogen could clearly be seen. The 
methylene protons of the ligands HL
1 
- HL
3
 appear as a doublet due to coupling to the 
NH proton of the sulfonamide group, whereas for HL
4
 and HL
5
 a triplet and an apparent 
quartet arise from the two methylene groups. Upon coordination to the gold, the 
methylene signals become either a singlet (for the five-membered ring systems) or two 
triplets (for the six-membered ring systems) providing unambiguous evidence for loss of 
the sulfonamide proton. 
 Coordination to the gold can clearly be seen in compounds L
1
AuCl2 (Figure 4) 
and L
2
AuCl2. A downfield shift of approximately 0.7 ppm is seen for H-1 (the proton 
adjacent to the coordinated pyridyl nitrogen) upon coordination to the gold, due to the 
proximity of the gold atom and the increased deshielding produced by the electron-
withdrawing metal centre. 
 For the complexes L
4
AuCl2 and L
5
AuCl2 there appears to be fluxionality in the 
six-membered auracyclic rings at 30 °C, though contribution from inversion of an amide 
nitrogen which is distorted from planarity, although unlikely, cannot be discounted. The 
two methylene signals are seen as broad triplets; presumably if the system was not 
fluxional the multiplets would be much more complex due to the different stereochemical 
environment each proton inhabits.  
 8 
 The main points of interest in the IR spectra of the complexes are the loss of NH 
stretching frequencies (~3100 cm
-1
) of the free ligands and a shift to lower wavenumbers 
for the SO2 stretching modes, consistent with lengthening of the S=O bonds through 
movement of electrons onto the sulfonyl oxygen atoms. For example, the SO2 stretches 
shift from 1164 cm
-1
 and 1327 cm
-1
 (for the asymmetric and symmetric stretches 
respectively) in HL
1
 to 1146 cm
-1
 and 1306 cm
-1
 in the cycloaurated complex L
1
AuCl2. 
 
ESI mass spectrometry 
 Analysis of the compounds L
1
AuCl2 – L
6
AuCl2 by ESI-MS was not overly 
effective for two reasons. Firstly, the compounds are neutral so must either pick up an ion 
(e.g. H
+
 or Na
+
) to be easily observed in the spectra or alternatively, coordination of a 
neutral species (e.g. pyridine) produces an easily detectable cation through displacement 
of Cl
-
.
15
 Secondly, because of the low ionisation ability of the neutral species, cationic 
impurity ions, namely the bis(cycloaurated) species such as [(L
2
)2Au]
+
, dominate the 
spectra as a result of their high ionisation efficiency, a phenomenon observed previously 
in cyclometallated gold(III) dichoride species.
16 
For example, when L
2
AuCl2 is analysed 
without ionisation aids (Figure 5a), the spectrum is dominated by the ion at m/z 691 due 
to [(L
2
)2Au]
+
, although there is no evidence for the presence of this species in either the 
1
H NMR spectrum or microanalytical results. Addition of NaCl to the sample before 
analysis produces ions at m/z 537 (21%) and 1051 (10%) corresponding to [L
2
AuCl2 + 
Na]
+
 and [2(L
2
AuCl2) + Na]
+
 respectively, however [(L
2
)2Au]
+
 is still the dominant peak. 
Addition of strongly coordinating pyridine (py) to a solution of the compound in 
methanol forms species identified as [L
2
AuCl(py)]
+
 and [L
2
Au(OMe)(py)]
+
 at m/z 558 
 9 
and 554 respectively, however the ion at m/z 691 (40%) is still present. Identification and 
confirmation of these ions is aided by the presence of chlorine(s) and thus unique isotope 
patterns. A similar pattern of behaviour was seen for all members of this family of 
compounds.
 
 
Biological activity 
 Previously, C,N cycloaurated complexes, in particular the compound 
(damp)AuCl2, (damp = 2-[(dimethylamino)methyl]phenyl) and its derivatives have 
shown promising antitumour activity.
17
 Little data exist on N,N’-stabilised cycloaurated 
complexes and for this reason complexes L
1
AuCl2 – L
5
AuCl2 were screened for 
antitumour activity against the P388 Murine Leukemia cell line. Results indicate an IC50 
value of greater than 12500 ng mL
-1
 for all compounds, indicating little activity against 
this particular cell line.   
 
Reactivity 
 When C,N cycloaurated dichloride species are reacted with tertiary phosphines, 
the chloride ligands may be displaced by coordination of the neutral phosphines to the 
gold or conversely, cleavage of the Au – N bond may occur with both Au – Cl bonds 
remaining intact; in each case gold(III) products are formed. Such reactions can give an 
indication of the strength of the gold-nitrogen bond and are dependent on the 
cycloaurated ligand present.
1
 
 Reaction of L
1
AuCl2 with PPh3 in a 1:1 molar ratio in dichloromethane resulted in 
lightening of the solution from yellow to pale yellow. ESI-MS of the solution showed 
 10 
ions corresponding to the gold(I) species [Au(PPh3)2]
+
 (m/z 721), PPh3 and Ph3P=O. 
31
P-
{
1
H} NMR spectroscopy of the solution gave peaks at δ 30 (br s) and 34 (s) ppm, the first 
of which arises from Ph3P=O, and the second from an average of rapidly exchanging 
[Au(PPh3)2]
+
 with free PPh3.
18
 Likewise, when L
1
AuCl2 was reacted with PPh3 in a 1:2 
ratio, ESI-MS gave ions due to [Au(PPh3)2]
+
, PPh3 and Ph3P=O; the 
31
P-{
1
H} NMR 
spectrum again showed peaks at δ 30 (s) and 34 (s) ppm. Reaction of L1AuCl2 with 
thiosalicylic acid using previously established methods
19
 resulted in immediate reduction 
and decomposition of the gold species to elemental gold. These results indicate that the 
N,N’ cycloaurated ligands are not as effective at stabilising the Au(III) centre as are C,N 
cycloaurated ligands, so reactions can result in reduction of the gold(III), suggesting that 
these complexes may have limited utility. 
 
Conclusions 
  Six new cycloaurated gold(III) complexes containing N,N’ cyclometallated 
ligands have been synthesised and fully characterised, including the X-ray crystal 
structures of two of these complexes. Coordination to the gold is through pyridyl and 
deprotonated amide nitrogen atoms. Unlike the more common analogous C,N 
cyclometallated compounds, these complexes show lower stability, as reactions with 
reducing agents leads to reduction of Au(III) to Au(I) or elemental gold. The biological 
activity of these complexes against murine leukaemia cell lines is also low – possibly due 
to this lack of stability towards reduction. 
 
 
 11 
Experimental 
 
General 
 All reactions were carried out with no efforts at excluding air. 2-Picolylamine, 
2-(2-aminoethyl)pyridine and 8-(p-tosylamino)quinoline (Aldrich) were used as supplied, 
as were p-toluenesulfonyl chloride (BDH), benzenesulfonyl chloride (BDH) and 
methanesulfonyl chloride (Riedel-de Haën). H[AuCl4].4H2O was synthesised from gold 
metal by the literature procedure,
20
 and yields of the dichloride complexes L
1
AuCl2 – 
L
6
AuCl2 are calculated assuming the above formulation. The sulfonamide ligands (all 
previously reported compounds
21,22,23
) were synthesised by the condensation of the 
appropriate sulfonyl chloride and amine, following the procedure reported for HL
1
and 
HL
4
.
24
  
 ESI mass spectra were obtained on a VG Platform II instrument operating at a 
cone voltage of 20 V, using methanol as the solvent after the compound was dissolved in 
a small amount of dichloromethane. IR spectra were recorded as KBr disks on a Digilab 
Scimitar FT-IR, and NMR spectra on a Bruker DRX 400 FT-NMR spectrometer, 
operating at 30 °C, with a series of 
1
H, 
13
C, DEPT-135, 
1
H-
1
H COSY, HMBC, HSQC 
and 1D-SELNOESY experiments utilised in the assignment of the NMR spectra. 
 Antitumour activities against the P388 murine leukemia cell line were determined 
at the University of Canterbury. Methods have been described previously,
25
 and samples 
were analysed as 1:1 dichloromethane/methanol solutions.   
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Synthesis of L
1
AuCl2  
HL
1
 (0.560 g, 2.13 mmol) and H[AuCl4].4H2O (0.877 g, 2.13 mmol) were added to water 
(75 mL) to give an orange suspension. This was refluxed with stirring for 3 h and cooled 
to room temperature. The orange precipitate that was present throughout the reaction was 
filtered, washed with water (2  10 mL) and isopropanol (2  10 mL) and air dried to 
give L
1
AuCl2 (0.918 g, 82%) as an orange solid. Found: C 29.6, H 2.5, N 5.3; 
C13H13N2SO2AuCl2 requires C 29.6, H 2.5, N 5.3 %. NMR (CDCl3): 
1
H δ 2.40 (s, 3H, H-
11), 4.88 (s, 2H, H-6), 7.26 (d, 
3
J9,8 = 8.5 Hz, 2H, H-9), 7.62 (ddd, 
3
J2,1 = 6.1 Hz, 
3
J2,3 = 
7.7 Hz, 
4
J2,4 = 1.6 Hz, 1H, H-2), 7.73 (dd, 
3
J4,3 = 7.8 Hz, 
4
J4,2 = 1.6 Hz, 1H, H-4), 7.87 (d, 
3
J8,9 = 8.5 Hz, 2H, H-8), 8.13 (td, 
3
J3,2 = 7.7 Hz, 
3
J3,4 = 7.8 Hz, 
4
J3,1 = 1.5 Hz, 1H, H-3), 
9.22 (dd, 
3
J1,2 = 6.1 Hz, 
4
J1,3 = 1.5 Hz, 1H, H-1); 
13
C-{
1
H}  δ 21.7 (C-11), 61.6 (C-6), 
121.7 (C-4), 125.5 (C-2), 127.8 (C-8), 129.7 (C-9), 138.0 (C-7), 143.2 (C-3), 143.6 (C-
10), 147.5 (C-1), 166.9 (C-5) (See Scheme 3 for NMR numbering scheme). ESI-MS: 
(NaCl added) m/z 551 (32%, [L
1
AuCl2+Na]
+
), 719 (100%, [(L
1
)2Au]
+
), 1079 (10%, 
[2(L
1
AuCl2)+Na]
+
); (pyridine added) m/z 568 (28%, [L
1
Au(OMe)(py)]
+
),
 
572 (100%, 
[L
1
AuCl(py)]
+
), 719 (25%, [(L
1
)2Au]
+
). IR: υ(SO2)sym 1306 (s), υ(SO2)asym 1146 (vs) cm
-
1
. 
 
Synthesis of L
2
AuCl2 
As for the synthesis of L
1
AuCl2, HL
2
 (0.566 g, 2.28 mmol) was suspended in an aqueous 
(50 mL) solution of H[AuCl4].4H2O (0.939 g, 2.28 mmol) and refluxed with stirring for 3 
h. The precipitate that was present throughout was filtered and washed with water (2  10 
mL) and isopropanol (2  10 mL). The yellow/brown solid was air dried to give  L2AuCl2 
 13 
(0.964 g, 82%). Found: C 27.9, H 2.1, N 5.4; C12H11N2SO2AuCl2 requires C 28.0, H 2.2, 
N 5.5 %. NMR (CDCl3): 
1
H  δ 4.91 (s, 2H, H-6), 7.47 (t, 3J9,10 = 8.0 Hz, 
3
J9,8 = 7.2 Hz,
 
2H, H-9), 7.53 (t, 
3
J10,9 = 8.0 Hz, 1H, H-10), 7.63 (ddd, 
3
J2,1 = 6.1 Hz, 
3
J2,3 = 7.6 Hz, 
4
J2,4 
= 1.6 Hz, 1H, H-2), 7.74 (dd, 
3
J4,3 = 7.8 Hz, 
4
J4,2 = 1.6 Hz, 1H, H-4), 7.99 (d, 
3
J8,9 = 7.2 
Hz, 2H, H-8), 8.13 (td, 
3
J3,2 = 7.6 Hz, 
3
J3,4 = 7.8 Hz, 
4
J3,1 = 1.5 Hz, 1H, H-3), 9.22 (dd, 
3
J1,2 = 6.1 Hz, 
4
J1,3 = 1.5 Hz, 1H, H-1);  
13
C-{
1
H} δ 61.6 (C-6), 121.7 (C-4), 125.5 (C-2), 
127.7 (C-8), 129.0 (C-9), 141.2 (C-7), 143.2 (C-3), 132.7 (C-10), 147.5 (C-1), 166.7 (C-
5)  (See Scheme 3 for NMR numbering scheme). ESI-MS: (NaCl added) m/z 537 (21%, 
[L
2
AuCl2+Na]
+
), 691 (100 %, [(L
2
)2Au]
+
), 1051 (10% [2(L
2
AuCl2)+Na]
+
; (pyridine 
added) m/z 554 (40%, [L
2
Au(OMe)(py)]
+
), 558 (100% [L
2
AuCl(py)]
+
), 691 (40%, 
[(L
2
)2Au]
+
). IR: υ(SO2)sym 1313 (s), υ(SO2)asym 1155 (vs) cm
-1
. 
 
Synthesis of L
3
AuCl2 
HL
3
 (0.200 g, 1.07 mmol) was dissolved in a solution of H[AuCl4].4H2O (0.441 g, 1.07 
mmol) in water (30 mL). Upon reaching reflux temperature, the yellow solution turned 
deep orange and remained this colour for the duration of the reflux (2 h). The clear 
solution was cooled in an ice bath which resulted in the deposition of orange/red 
microcrystals. These were filtered and washed with water (2  10 mL) and isopropanol (2 
 10 mL) and air dried to give L3AuCl2 (0.266 g, 55%). Found: C 18.1, H 1.9, N 6.0; 
C7H9N2SO2AuCl2 requires C 18.6, H 2.0, N 6.2 %. NMR (d6-DMSO): 
1
H δ 3.10 (s, 3H, 
H-7), 4.96 (s, 2H, H-6), 7.80 (ddd, 
3
J2,1 = 6.2 Hz, 
3
J2,3 = 7.6 Hz, 
4
J2,4 = 1.2 Hz, 1H, H-2), 
8.05 (dd, 
3
J4,3 = 7.7 Hz, 
4
J4,2 = 1.2 Hz, 1H, H-4), 8.33 (td, 
3
J3,2 = 7.6 Hz, 
3
J3,4 = 7.7 Hz, 
4
J3,1 = 1.4 Hz, 1H, H-3), 9.04 (dd, 
3
J1,2 = 6.2 Hz, 
4
J1,3 = 1.4 Hz, 1H, H-1);  
13
C-{
1
H}  δ 
41.9 (C-7), 61.1 (C-6), 122.1 (C-4), 125.6 (C-2), 143.8 (C-3), 146.5 (C-1), 166.2 (C-5) 
 14 
(See Scheme 3 for NMR numbering scheme). ESI-MS: (NaCl added) m/z 475 (100%, 
[L
3
AuCl2+Na]
+
), 567 (84%, [(L
3
)2Au]
+
), 927 (56%, [2(L
3
AuCl2)+Na]
+
);  (pyridine 
added) m/z  492 (45%, [L
3
Au(OMe)(py)]
+
), 496 (100%, [L
3
AuCl(py)]
+
). IR: υ(SO2)sym 
1306 (s), υ(SO2)asym 1132 (vs) cm
-1
. 
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Scheme 3:  NMR numbering scheme for L
1
AuCl2 – L
3
AuCl2. For complex L
3
AuCl2, the methyl 
carbon is labelled C-7. Hydrogens are labelled according to the carbon they are 
directly bonded to. 
 
 
Synthesis of L
4
AuCl2 
To an aqueous (30 mL) solution of H[AuCl4].4H2O (0.531 g, 1.29 mmol), HL
4
 (0.357 g, 
1.29 mmol) was added and the yellow solution refluxed with stirring for 3.5 h. During 
this time a brown solid formed, which after cooling was filtered, dried and washed with 
water (2  10 mL) and ether (10 mL) to give L4AuCl4 (0.542 g, 78%). Found: C 31.1, H 
2.9, N 5.3; C14H15N2SO2AuCl2 requires C 31.0, H 2.8, N 5.2 %. NMR (d6-DMSO): 
1
H  δ 
2.31 (s, 3H, H-12), 3.23 (br t, 2H, H-7), 3.47 (t, 
3
J6,7 = 6.3 Hz, 2H, H-6), 7.19 (d, 
3
J10,9 = 
8.2 Hz, 2H, H-10), 7.57 (d, 
3
J9,10 = 8.2 Hz, 2H, H-9), 7.74 (ddd, 
3
J2,1 = 6.0 Hz, 
3
J2,3 = 7.7 
Hz, 
4
J2,4 = 1.5 Hz, 1H, H-2), 7.77 (dd, 
3
J4,3 = 7.8 Hz, 
4
J4,2 = 1.5 Hz, 1H, H-4), 8.26 (td, 
1H, 
3
J3,2 = 7.7 Hz, 
3
J3,4 = 7.8 Hz, 
4
J3,1 = 1.4 Hz, 1H, H-3), 8.91 (dd, 
3
J1,2 = 6.0 Hz, 
4
J1,3 = 
1.4 Hz, 1H, H-1); 
13
C-{
1
H} δ 20.8 (C-12), 37.6 (C-6), 42.4 (C-7), 126.0 (C-2), 126.8 (C-
 15 
9), 127.7 (C-4), 129.4 (C-10), 137.8 (C-8), 142.2 (C-11), 143.8 (C-3), 149.7 (C-1), 155.5 
(C-5) (See Scheme 4 for NMR numbering scheme). ESI-MS: (NaCl added) m/z 565 
(100%, [L
4
AuCl2+Na]
+
), 747 (91%, [(L
4
)2Au]
+
), 1107 (19%, [2(L
4
AuCl2)+Na]
+
); 
(pyridine added) m/z 582 (50%, [L
4
Au(OMe)(py)]
+
), 586 (100%, [L
4
AuCl(py)]
+
). IR: 
υ(SO2)sym 1311 (s), υ(SO2)asym 1148 (vs) cm
-1
. 
 
Synthesis of L
5
AuCl2 
HL
5
 (0.329 g, 1.25 mmol) and aqueous (30 mL) H[AuCl4].4H2O (0.515 g, 1.25 mmol) 
were refluxed with stirring for 3 h, resulting in the formation of a red/orange precipitate. 
This was filtered, washed with water (2  10 mL) and isopropanol (10 mL). The crude 
product was recrystallised by dissolving in minimum dichloromethane, filtering off the 
insoluble yellow precipitate, and adding diethyl ether to the filtrate until the solution went 
cloudy. The resulting dark red crystals were filtered and washed with diethyl ether (2  
10 mL) and dried to give L
5
AuCl2 (0.436 g, 66%). Found: C 29.7, H 2.6, N 5.4; 
C13H13N2SO2AuCl2 requires C 29.5, H 2.5, N 5.3 %. NMR (d6-DMSO): 
1
H  δ 3.25 (br t, 
2H, H-7), 3.48 (t, 
3
J6,7 = 6.4 Hz, 2H, H-6), 7.41 (t, 
3
J10,11 = 7.5 Hz, 
3
J10,9 = 7.0 Hz,
 
2H, H-
10), 7.48 (t, 
3
J11,10 = 7.5 Hz, 1H, H-11), 7.70 (d, 
3
J9,10 = 7.0 Hz, 2H, H-9), 7.75 (ddd, 
3
J2,1 
= 6.0 Hz, 
3
J2,3 = 7.8 Hz, 
4
J2,4 = 1.7 Hz, 1H, H-2), 7.77 (dd, 
3
J4,3 = 7.7 Hz, 
4
J4,2 = 1.7 Hz, 
1H, H-4), 8.25 (td, 
3
J3,2 = 7.8 Hz, 
3
J3,4 = 7.7 Hz, 
4
J3,1 = 1.4 Hz, 1H, H-3), 8.95 (dd, 
3
J1,2 = 
6.0 Hz, 
4
J1,3 = 1.4 Hz, 1H, H-1); 
13
C-{
1
H} δ 37.6 (C-6), 42.4 (C-7), 126.0 (C-2), 126.7 
(C-9), 127.7 (C-4), 128.9 (C-10), 131.9 (C-11), 140.6 (C-8), 143.9 (C-3), 149.7 (C-1), 
155.5 (C-5) (See Scheme 4 for NMR numbering scheme). ESI-MS: (NaCl added) m/z 
547 (55%, [L
5
Au(OMe)Cl+Na]
+
), 551 (100%, [L
5
AuCl2+Na]
+
), 1079 (25%, 
 16 
[2(L
5
AuCl2)+Na]
+
); (pyridine added) m/z 568 (100%, [L
5
Au(OMe)(py)]
+
), 572 (78%, 
[L
5
AuCl(py)]
+
). IR: υ(SO2)sym 1320 (s), υ(SO2)asym 1149 (vs) cm
-1
. 
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Scheme 4: NMR numbering scheme for L
4
AuCl2 and L
5
AuCl2. Hydrogens are labelled according 
to the carbon they are directly bonded to. 
 
Synthesis of L
6
AuCl2 
8-(p-Tosylamino)quinoline (0.176 g, 0.590 mmol) was suspended in aqueous (30 mL) 
H[AuCl4].4H2O (0.243 g, 0.590 mmol) and refluxed with stirring for 8 h. When the 
mixture reached reflux temperature, a brown solid formed that remained present 
throughout the duration of the reaction. The mixture was allowed to cool before being 
filtered, washed with H2O (2  10 mL) and isopropanol (2  10 mL) and dried under 
vacuum, to give L
6
AuCl2 as a brown solid (0.241 g, 72 %). Found: C 33.9, H 2.3, N 5.0; 
C16H13N2SO2AuCl2 requires C 34.0, H 2.3, N 5.0 %. NMR (d6-DMSO): 
1
H δ 2.30 (s, 3H, 
H-14), 7.26 (d, 
3
J11,10 = 8.3 Hz, 2H, H-12), 7.67 (d, 
3
J10,11 = 8.3 Hz 2H, H-11), 7.76 (t, 
3
J6,7/5 = 7.7 Hz, 1H, H-6), 7.81 (dd, 
3
J7,6 = 7.7 Hz, 
4
J7,5 = 1.6 Hz, 1H, H-7), 7.86 (dd, 
3
J5,6 
= 7.7 Hz, 
4
J5,7 = 1.6 Hz, 1H, H-5), 7.93 (dd, 
3
J2,1 = 5.6 Hz, 
3
J2,3 = 8.3 Hz, 1H, H-2), 8.92 
(dd, 
3
J3,2 = 8.3 Hz, 
4
J3,1 = 1.1 Hz, 1H, H-3), 9.21 (dd, 
3
J1,2 = 5.6 Hz, 
4
J1,3 = 1.1 Hz, 1H, H-
1); 
13
C-{
1H} δ  21.1 (C-14), 123.5 (C-2), 124.3 (C-5), 125.9 (C-7), 126.8 (C-11), 129.7 
 17 
(C-12), 130.0 (C-6), 130.7 (C-4), 138.8 (C-10), 143.3 (C-13), 143.7 (C-9), 144.0 (C-3), 
146.0 (C-8), 148.1 (C-1) (see Scheme 5 for NMR numbering scheme). ESI-MS: (NaCl 
added) m/z 587 (100%, [L
6
AuCl2+Na]
+
); (pyridine added) m/z 608 (100%, 
[L
6
AuCl(py)]
+
), 604 (35%, [L
5
Au(OMe)(py)]
+
). IR: υ(SO2)sym 1326 (s), υ(SO2)asym 1158 
(vs) cm
-1
. 
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Scheme 5: NMR numbering scheme for L
6
AuCl2. Hydrogens are labelled according to the carbon 
they are directly bonded to. 
 
Attempted preparation of L
7
AuCl2  
(i) Reflux with H[AuCl4] in water 
HL
7
 (0.310 g, 1.25 mmol) was refluxed with stirring in aqueous (30 mL) 
H[AuCl4].4H2O (0.515 g, 1.25 mmol) for 1 h, after which a brown solid had formed. 
When cool, the solution was filtered and the solid washed with water (2  10 mL) and 
isopropanol (10 mL) to give 0.188 g (26%) of a brown solid, which was identified as 
the salt [H2L
7
][AuCl4]. NMR (CDCl3): 
1H  δ (ppm)  2.38 (s, 3H, H-10), 6.80 (ddd, 
3
J2,1 = 5.9 Hz, 
3
J2,3 = 7.1 Hz, 
4
J2,4 = 1.1Hz, 1H, H-2), 7.24 (d, 
3
J8,7 = 8.1 Hz, 2H, H-8), 
7.40 (dd, 
3
J4,3 = 8.9 Hz, 
4
J4,2 = 1.1 Hz, 1H, H-4), 7.64 (ddd, 
3
J3,2 = 7.1 Hz, 
3
J3,4 = 8.9 
 18 
Hz, 
4
J3,1 = 1.9 Hz, 1H, H-3), 7.79 (d, 
3
J7,8 = 8.1 Hz, 2H, H-7), 8.34 (dd, 
3
J1,2 = 5.9 Hz, 
4
J1,3 = 1.9 Hz, 1H, H-1), NH not observed; 
13
C-{
1
H} δ  21.6 (C-10), 114.7 (C-2), 
115.1 (C-4), 127.0 (C-7), 129.7 (C-8), 138.8 (C-6), 141.5 (C-1), 141.9 (C-3), 143.1 
(C-9), 155.0 (C-5) (see Scheme 6 for NMR numbering scheme). ESI-MS: (positive 
ion, cone voltage 20V): m/z 249 (100%, [H2L
7
]
+
); (negative ion, cone voltage 20V): 
m/z 339 (100%, [AuCl4]
-
). 
 
(ii) Standing with H[AuCl4] in MeCN/H2O solution 
HL
7
 (0.108 g, 0.43 mmol) was dissolved in MeCN (5 mL) and added dropwise to 
aqueous (20 mL) H[AuCl4].4H2O (0.177 g, 0.43 mmol). The solution was left to 
stand and after 2 weeks a light brown solid had formed. This was filtered and washed 
with water (2  10 mL) and ether (1  10 mL), to give 0.078 g (31%) of 
[H2L
7
][AuCl4], which was identified by ESI-MS and 
1
H NMR spectroscopy. 
 
(iii) Refluxing in 1:1 MeCN/H2O 
HL
7
 (0.050 g, 0.20 mmol) and H[AuCl4].4H2O (0.082 g, 0.20 mmol) were refluxed in 
aqueous (20 mL) MeCN (1:1) with stirring for 3 h. The solution was left to stand 
overnight and brown crystals were formed. These were subsequently identified as 
[H2L
7
][AuCl4] (0.037g, 31%). 
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Scheme 6: NMR numbering scheme for [H2L
7
][AuCl4]. Hydrogens are labelled according to the 
carbon they are directly bonded to. 
 
X-ray crystal structure determinations of L
3
AuCl2 and L
6
AuCl2 
 Single crystals of L
3
AuCl2 and L
6
AuCl2 suitable for X-ray structure analysis were 
obtained by slow diffusion of diethyl ether into a dichloromethane solution of the 
compounds, at room temperature and -20 °C respectively. L
3
AuCl2 crystallised as orange 
prisms with two independent molecules per unit cell, and L
6
AuCl2 as brown cubes as a 
CH2Cl2 solvate. 
 Intensity data and unit cell dimensions were obtained at the University of 
Auckland on a Bruker Smart CCD Diffractometer (L
3
AuCl2) and at the University of 
Canterbury on a Bruker Apex II Diffractometer (L
6
AuCl2). The data were corrected for 
absorption using SADABS.
26
 
 The structures of L
3
AuCl2 and L
6
AuCl2 were solved using the Patterson and 
Direct methods options of SHELXS-97
27
 respectively. The gold atom was initially located, 
followed by the location of all other non-hydrogen atoms by a series of difference maps. 
Full-matrix least-squares refinement (SHELXL-97)
28
 was based upon Fo
2
 with all non-
hydrogen atoms anisotropic, and hydrogen atoms in calculated positions.   
 Crystal and refinement data for the complexes are presented in Table 3. CCDC 
reference numbers 676314 and 676315 for L
3
AuCl2 and L
6
AuCl2 respectively. 
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Table 1:  A comparison of selected bond lengths (Å) for the crystal structures of L
3
AuCl2 
(two independent molecules) and L
6
AuCl2 
 
 
 L
3
AuCl2 
L
6
AuCl2 
 Molecule 1 Molecule 2 
Au(1) – Cl(1) 2.2872(10) 2.2807(10) 2.2789(8) 
Au – Cl(2) 2.2720(10) 2.2800(10) 2.2637(9) 
Au – N (ex py) 2.046(3) 2.037(3) 2.026(3) 
Au – N (ex NH) 2.006(3) 2.021(3) 2.038(3) 
 
 
 
 
 
 
 
 
 
Table 2:  A comparison of selected bond angles (°) for the crystal structures of 
L
3
AuCl2 (including the two independent molecules) and L
6
AuCl2 
 
 
 L
3
AuCl2 
L
6
AuCl2 
 Molecule 1 Molecule 2 
Cl(1) – Au(1)– Cl(2) 89.09(4) 90.17(4) 88.13(3) 
Cl(1) – Au(1) – N(ex. py) 94.08(10) 93.89(10) 94.36(8) 
N(ex py) – Au(1) – N(ex NH) 78.98(13) 82.09(13) 81.48(11) 
N(ex NH) – Au(1) – Cl(2) 98.02(10) 93.79(10) 95.88(8) 
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Table 3: Crystal and refinement data for the complexes L
3
AuCl2 and L
6
AuCl2 
 
Complex L
3
AuCl2 L
6
AuCl2 
Formula C7H9AuCl2N2O2S C16H13AuCl2N2O2S · CH2Cl2 
Mr 453.09 650.14 
T/K 89 93 
Crystal system Triclinic Monoclinic 
Space group P(-1) P21/n 
a (Å) 7.3424(1) 14.1782(6) 
b (Å) 9.2813(1) 10.6792(5) 
c (Å) 17.2700(2) 14.4771(6) 
 (°) 99.383(1) 90 
 (°) 95.785(1) 115.147(2) 
γ (°) 102.127(1) 90 
V (Å3) 1124.06(2) 1984.2(2) 
Z 4 4 
Dcalc (g cm
-3) 2.677 2.176 
Tmax,min 0.1699, 0.1138  0.2950, 0.0597 
Number of unique reflections 4562 6252 
Number of observed reflections [I>2σ(I)] 4360 5476 
R [I>2σ(I)] 0.0203 0.0293 
wR2 (all data) 0.0512 0.0868 
Goodness of Fit 1.117 1.046 
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Figure 1:  Molecular structure of L
3
AuCl2, showing one of the independent molecules present in 
the unit cell, and the atom numbering scheme.   
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Figure 2:  Molecular structure of L
6
AuCl2, showing the atom numbering scheme, with the 
dichloromethane solvent omitted for clarity. 
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Figure 3:  a) Structure of L
3
AuCl2 (molecule 1) showing the envelope conformation of the 
cycloaurated ring with N(2) sitting above the plane of the ring; b) crystal structure of L
6
AuCl2 
showing the planarity of the quinoline group, with Au(1) sitting below the plane. For clarity, only 
the ipso carbon of the p-tolyl group of L
6
AuCl2 is shown and hydrogen atoms are omitted. 
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Figure 4:  
1
H NMR spectra (CDCl3, 300 MHz) of a) HL
1
 and b) L
1
AuCl2, showing changes in 
spectra upon coordination of the ligand to gold. 
 
 
 
 
 
a) 
b) 
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Figure 5:  Positive ion ESI mass spectra (cone voltage 20 V, MeOH solvent) of L
2
AuCl2 showing 
the observed ions under different ionisation conditions: a) neat solution; b) with addition of NaCl; 
c) with addition of pyridine (py). 
 
 
 
 
 
 
 
a) 
b) 
c) 
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